과제정보
This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2020R1I1A1A01070020 to EMK, NRF-2021R1A6A3A01087300 to JEK, NRF-2018M3A9C8020027, NRF-2020R1A2C3008993, and NRF-2021M3A9D3024752 to JWL).
참고문헌
- Sveen A, Kopetz S and Lothe RA (2020) Biomarker-guided therapy for colorectal cancer: strength in complexity. Nat Rev Clin Oncol 17, 11-32 https://doi.org/10.1038/s41571-019-0241-1
- Wang F, Breslin SJP and Qiu W (2021) Novel oncogenes and tumor suppressor genes in hepatocellular carcinoma. Liver Res 5, 195-203 https://doi.org/10.1016/j.livres.2021.06.001
- Lee SA, Lee SY, Cho IH et al (2008) Tetraspanin TM4SF5 mediates loss of contact inhibition through epithelial-mesenchymal transition in human hepatocarcinoma. J Clin Invest 118, 1354-1366
- Ahn H-M, Ryu J, Song JM et al (2017) Anti-cancer activity of novel TM4SF5-targeting antibodies through TM4SF5 neutralization and immune cell-mediated cytotoxicity. Theranostics 7, 594-613 https://doi.org/10.7150/thno.15629
- Ryu J, Kim E, Kang M-K et al (2021) Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression. J Pathol 253, 55-67 https://doi.org/10.1002/path.5548
- Kang M, Jeong SJ, Park SY et al (2012) Antagonistic regulation of transmembrane 4 L6 family member 5 attenuates fibrotic phenotypes in CCl4 -treated mice. FEBS J 279, 625-635 https://doi.org/10.1111/j.1742-4658.2011.08452.x
- Sun H, Kim E, Ryu J et al (2021) TM4SF5-mediated liver malignancy involves NK cell exhaustion-like phenotypes. Cell Mol Life Sci 79, 49
- Ren J, Sui H, Fang F, Li Q and Li B (2019) The application of ApcMin/+ mouse model in colorectal tumor researches. J Cancer Res Clin Oncol 145, 1111-1122 https://doi.org/10.1007/s00432-019-02883-6
- Shih SC, Zukauskas A, Li D et al (2009) The L6 protein TM4SF1 is critical for endothelial cell function and tumor angiogenesis. Cancer Res 69, 3272-3277 https://doi.org/10.1158/0008-5472.CAN-08-4886
- Lee JW (2015) Transmembrane 4 L six family member 5 (TM4SF5)-mediated epithelial-mesenchymal transition in liver diseases. Int Rev Cell Mol Biol 319, 141-163 https://doi.org/10.1016/bs.ircmb.2015.06.004
- Powell SM, Zilz N, Beazer-Barclay Y et al (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359, 235-237 https://doi.org/10.1038/359235a0
- Yamada Y and Mori H (2007) Multistep carcinogenesis of the colon in Apc(Min/+) mouse. Cancer Sci 98, 6-10 https://doi.org/10.1111/j.1349-7006.2006.00348.x
- Grill JI, Herbst A, Brandl L et al (2015) Inactivation of Itf2 promotes intestinal tumorigenesis in Apc(Min/+) mice. Biochem Biophys Res Commun 461, 249-253 https://doi.org/10.1016/j.bbrc.2015.04.009
- Jung YS and Park JI (2020) Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex. Exp Mol Med 52, 183-191 https://doi.org/10.1038/s12276-020-0380-6
- Lee H, Kim E, Shin EA et al (2022) Crosstalk between TM4SF5 and GLUT8 regulates fructose metabolism in hepatic steatosis. Mol Metab 58, 101451
- McConnell M and Iwakiri Y (2018) Biology of portal hypertension. Hepatol Int 12, 11-23 https://doi.org/10.1007/s12072-017-9826-x
- Kim S, Cho CY, Lee D et al (2018) CD133-induced TM4SF5 expression promotes sphere growth via recruitment and blocking of protein tyrosine phosphatase receptor type F (PTPRF). Cancer Lett 438, 219-231 https://doi.org/10.1016/j.canlet.2018.09.009
- Shakoori A, Mai W, Miyashita K et al (2007) Inhibition of GSK-3β activity attenuates proliferation of human colon cancer cells in rodents. Cancer Sci 98, 1388-1393 https://doi.org/10.1111/j.1349-7006.2007.00545.x
- Pal K, Cao Y, Gaisina IN et al (2014) Inhibition of GSK-3 induces differentiation and impaired glucose metabolism in renal cancer. Mol Cancer Ther 13, 285-296 https://doi.org/10.1158/1535-7163.MCT-13-0681
- Garcea G, Manson MM, Neal CP et al (2007) Glycogen synthase kinase-3β; a new target in pancreatic cancer? Curr Cancer Drug Targets 7, 209-215 https://doi.org/10.2174/156800907780618266
- Ma C, Wang J, Gao Y et al (2007) The role of glycogen synthase kinase 3β in the transformation of epidermal cells. Cancer Res 67, 7756-7764 https://doi.org/10.1158/0008-5472.CAN-06-4665
- Farago M, Dominguez I, Landesman-Bollag E et al (2005) Kinase-inactive glycogen synthase kinase 3β promotes Wnt signaling and mammary tumorigenesis. Cancer Res 65, 5792-5801 https://doi.org/10.1158/0008-5472.CAN-05-1021
- Zheng H, Saito H, Masuda S, Yang X and Takano Y (2007) Phosphorylated GSK3β-ser9 and EGFR are good prognostic factors for lung carcinomas. Anticancer Res 27, 3561-569
- Noe O, Filipiak L, Royfman R et al (2021) Adenomatous polyposis coli in cancer and therapeutic implications. Oncol Rev 15, 534
- Choi S, Lee S-A, Kwak TK et al (2009) Cooperation between integrin α5 and tetraspan TM4SF5 regulates VEGF-ediated angiogenic activity. Blood 113, 1845-1855 https://doi.org/10.1182/blood-2008-05-160671
- Lee SA, Kim TY, Kwak TK et al (2010) Transmembrane 4 L six family member 5 (TM4SF5) enhances migration and invasion of hepatocytes for effective metastasis. J Cell Biochem 111, 59-66
- Jung O, Choi YJ, Kwak TK et al (2013) The COOH-terminus of TM4SF5 in hepatoma cell lines regulates c-Src to form invasive protrusions via EGFR Tyr845 phosphorylation. Biochim Biophys Acta 1833, 629-642 https://doi.org/10.1016/j.bbamcr.2012.11.026
- Lee D and Lee JW (2015) Self-renewal and circulating capacities of metastatic hepatocarcinoma cells required for collaboration between TM4SF5 and CD44. BMB Rep 48, 127-128 https://doi.org/10.5483/BMBRep.2015.48.3.047
- Juanes MA (2020) Cytoskeletal control and Wnt signaling-PC's dual contributions in stem cell division and colorectal cancer. Cancers (Basel) 12, 3811
- Barzegar Behrooz A, Syahir A and Ahmad S (2018) CD133: beyond a cancer stem cell biomarker. J Drug Target 27, 257-269 https://doi.org/10.1080/1061186x.2018.1479756
- Ma S (2013) Biology and clinical implications of CD133(+) CD133(+) liver cancer stem cells. Exp Cell Res 319, 126-132 https://doi.org/10.1016/j.yexcr.2012.09.007
- Song HE LY, Kim E, Cho CY et al (2021) N-terminus-independent activation of c-Src via binding to a tetraspan (in) TM4SF5 in hepatocellular carcinoma is abolished by the TM4SF5 C-terminal peptide application. Theranostics 11, 8092-8111 https://doi.org/10.7150/thno.58739
- Turkson J, Bowman T, Garcia R, Caldenhoven E, De Groot RP and Jove R (1998) Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol Cell Biol 18, 2545-2552 https://doi.org/10.1128/MCB.18.5.2545
- Boivin D, Labbe D, Fontaine N et al (2009) The stem cell marker CD133 (prominin-1) is phosphorylated on cytoplasmic tyrosine-828 and tyrosine-852 by Src and Fyn tyrosine kinases. Biochemistry 48, 3998-4007 https://doi.org/10.1021/bi900159d
- Wei Y, Jiang Y, Zou F et al (2013) Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells. Proc Natl Acad Sci U S A 110, 6829-6834 https://doi.org/10.1073/pnas.1217002110
- Ko D, Kim E, Shin EA et al (2022) Therapeutic effects of TM4SF5-targeting chimeric and humanized monoclonal antibodies in hepatocellular and colon cancer models. Mol Ther Oncolytics 24, 452-466 https://doi.org/10.1016/j.omto.2022.01.006
- Kang M, Choi S, Jeong SJ et al (2012) Cross-talk between TGFβ1 and EGFR signalling pathways induces TM4SF5 expression and epithelial-mesenchymal transition. Biochem J 443, 691-700 https://doi.org/10.1042/BJ20111584
- Lee D, Na J, Ryu J et al (2015) Interaction of tetraspan (in) TM4SF5 with CD44 promotes self-renewal and circulating capacities of hepatocarcinoma cells. Hepatology 61, 1978-1997 https://doi.org/10.1002/hep.27721
- Kim E, Um H, Park J et al (2021) TM4SF5-dependent cross-talk between hepatocytes and macrophages to reprogram the inflammatory environment. Cell Rep 37, 110018